Details

Autor(en) / Beteiligte

• Woudenberg, Tom
• van der Maas, Nicoline A. T.
• Knol, Mirjam J.
• de Melker, Hester
• van Binnendijk, Rob S.
• Hahné, Susan J. M.

Titel

Effectiveness of Early Measles, Mumps, and Rubella Vaccination Among 6—14–Month–Old Infants During an Epidemic in the Netherlands: An Observational Cohort Study

Ist Teil von

• The Journal of infectious diseases, 2017-04, Vol.215 (8), p.1181-1187

Ort / Verlag

US: Oxford University Press

Erscheinungsjahr

2017

Link zum Volltext

Quelle

Oxford Journals 2020 Medicine

Beschreibungen/Notizen

• Background. Routinely, the first measles, mumps, and rubella (MMR) vaccine dose is given at 14 months of age in the Netherlands. However, during a measles epidemic in 2013–2014, MMR vaccination was also offered to 6–14-month-olds in municipalities with <90% MMR vaccination coverage. We studied the effectiveness of the early MMR vaccination schedule. Methods. Parents of all infants targeted for early MMR vaccination were asked to participate. When parent(s) suspected measles, their infant's saliva was tested for measles-specific antibodies. The vaccine effectiveness (VE) against laboratory-confirmed and self-reported measles was estimated using Cox regression, with VE calculated as 1 minus the hazard ratio. Results. Three vaccinated and 10 unvaccinated laboratory-confirmed cases occurred over observation times of 106 631 and 23 769 days, respectively. The unadjusted VE against laboratory-confirmed measles was 94% (95% confidence interval [CI], 79%– 98%). After adjustment for religion and sibling's vaccination status, the VE decreased to 71% (−72%–95%). For self-reported measles, the unadjusted and adjusted VE was 67% (40%–82%) and 43% (−12%–71%), respectively. Conclusions. Infants vaccinated between 6 and 14 months of age had a lower risk of measles than unvaccinated infants. However, part of the effect was caused by herd immunity, since vaccinated infants were more likely to be surrounded by other vaccinated individuals.